Statistics
Total Visits
Views | |
---|---|
HAPTOGLOBIN PHENOTYPE, HDL-CHOLESTEROL RAISING THERAPY (FIBRATE), AND RISK OF CARDIOVASCULAR DISEASE EVENTS WITHIN THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) LIPID TRIAL | 85 |
Total Visits Per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
HAPTOGLOBIN PHENOTYPE, HDL-CHOLESTEROL RAISING THERAPY (FIBRATE), AND RISK OF CARDIOVASCULAR DISEASE EVENTS WITHIN THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) LIPID TRIAL | 0 | 7 | 11 | 0 | 4 | 5 | 1 |
File Visits
Views | |
---|---|
Warren-Rachel-MSc-CH&E-August-2020.pdf | 307 |
Top country views
Views | |
---|---|
United States | 57 |
Vietnam | 5 |
Ireland | 4 |
Canada | 3 |
Bulgaria | 2 |
China | 2 |
Sweden | 2 |
Australia | 1 |
Indonesia | 1 |
India | 1 |
Top cities views
Views | |
---|---|
Blue Bell | 11 |
Houston | 9 |
Oakland | 8 |
Wilmington | 6 |
Fairfield | 5 |
Hanoi | 5 |
Dublin | 4 |
Palo Alto | 3 |
Halifax | 2 |
Menlo Park | 2 |